An unexpected role for p53 in augmenting SV40 large T antigen-mediated tumorigenesis

Biological Chemistry

Volumn 380, Issue 2, 1999, Pages 203-211

  Herzig, Michaela ^a   Novatchkova, Maria ^a   Christofori, Gerhard ^a  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

Author keywords

SV40 large T antigen; Transgenic mice; Tumor suppressor p53; Tumorigenesis

Indexed keywords

PROTEIN P53; VIRUS LARGE T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; INSULINOMA; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SIMIAN VIRUS 40; TRANSGENIC MOUSE; TUMOR VOLUME; VIRUS CARCINOGENESIS;

ANIMALIA; MUS MUSCULUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0033015334     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/bc.1999.028     Document Type: Article

References (37)

1. Alpert, S., Hanahan, D., and Teitelman, G. (1988). Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 53, 295-308.
2. Bates, S., and Vousden, K.H. (1996). p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6, 12-19.
3. Carbone, M., Rizzo, P., Grimley, P.M., Procopio, A., Mew, D.J., Shridhar, V., de Bartolomeis, A., Esposito, V., Giuliano, M.T., Steinberg, S.M., Levine, A.S., Giordano, A., and Pass, H.I. (1997). Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nature Med. 3, 908-912.
4. Chandrasekaran, C., Coopersmith, C.M., and Gordon, J.I. (1996). Use of normal and transgenic mice to examine the relationship between terminal differentiation of intestinal epithelial cells and accumulation of their cell cycle regulators. J. Biol. Chem. 271, 28414-28421.
5. Christofori, G., Naik, P., and Hanahan, D. (1994). A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369, 414-418.
6. Christofori, G., Naik, P., and Hanahan, D. (1995). Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol. Endocrinol. 9, 1760-1770.
7. DeLuca, A., Baldi, A., Esposito, V., Howard, C.M., Bagella, L., Rizzo, P., Caputi, M., Pass, H.I., Giordano, G.G., Baldi, F., Carbone, M., and Giordano, A. (1997). The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nature Med. 3, 913-916.
8. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Butel, J.S., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptiple to spontaneous tumours. Nature 356, 215-221.
9. Efrat, S., Baekkeskov, S., Lane, D., and Hanahan, D. (1987). Coordinate expression of the endogeneous p53 gene in β cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes. EMBO J. 6, 2699-2704.
10. Efrat, S., Linde, S., Kofod, H., Spector, D., Delannoy, M., Grant, S., Hanahan, D., and Baekkeskov, S. (1988). Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc. Natl. Acad. Sci. USA 85, 9037-9041.
11. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58-61.
12. Hall, P.A., and Lane, D.P. (1997). A developing role for p53? Curr. Biol. 7, 144-147.
13. Hanahan, D. (1985). Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/ simian 40 oncogenes. Nature 315, 115-122.
14. Harper, J.W., and Elledge, J. (1996). Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6, 56-64.
15. Hoppe-Seyler, F., and Butz, K. (1995). Molecular mechanisms of virus-induced carcinogenesis: the interaction of viral factors with cellular tumor suppressor proteins. J. Mol. Med. 73, 529-538.
16. Howes, K.A., Ransom, N. Papermaster, D.S., Lasudry, J.G.H., Albert, D.M., and Windle, J.J. (1994). Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes & Dev. 8, 1300-1310.
17. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T., and Weinberg, R.A. (1994). Tumor spectrum analysis in p53-mutant mice. Curr. Biol. 4, 1-7.
18. Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-332.
19. Li, M., Hu, J., Heermeier, K., Henninghausen, L., and Furth, P. (1995). Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells. Cell Growth Diff. 7, 3-11.
20. Ludlow, J.W. (1993). Interactions between SV40 large-tumor antigen and the growth suppressor proteins pRB and p53. FASEB J. 7, 866-871.
21. Ludlow, J.W., and Skuse, G.R. (1995). Viral oncoprotein binding to pRb, p107, p130, and p300. Virus Res. 35, 113-121.
22. Manfredi, J.J., and Prives, C. (1994). The transforming activity of simian virus 40 large tumor antigen. Biochim. Biophys. Acta 1198, 65-83.
23. Martin, K., Trouche, D., Hagemeier, C., Sorensen, T.S., LaThangue, N.B., and Kouzarides, T. (1995). Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375, 691-694.
24. Martin-Zanca, D., Oskam, R., Mitra, G., Copeland, T., and Barbacid, M. (1989). Molecular and biochemical characterization of the human trk proto-oncogene. Mol. Cell. Biol. 9, 24-33.
25. Naik, P., Karrim, J., and Hanahan, D. (1996). The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 10, 2105-2116.
26. Pan, H., and Griep, A.E. (1995). Temporally distinct patterns of p53-dependent and p53-independent apoptosis during mouse lens development. Genes & Dev. 9, 2157-2169.
27. Perl, A.-K., Wilgenbus, P., Dahl, U., Semb, H., and Christofori, G. (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190-193.
28. Shibata, M.A., Maroulakou, I.G., Jorcyk, C.L., Gold, L.G., Ward, J.M., and Green, J.E. (1996). p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma. Cancer Res. 56, 2998-3003.
29. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T. (1994). p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78, 703-711.
30. Teitelman, G., Alpert, S., and Hanahan, D. (1988). Proliferation, senescence, and neoplastic progression of β cells in hyperplasic pancreatic islets. Cell 52, 97-105.
31. Tiemann, F., and Deppert, W. (1994a). Immortalization of Balb/c mouse embryo fibroblasts alters SV40 large T antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation efficiency. Oncogene 9, 1907-1915.
32. Tiemann, F., and Deppert, W. (1994b). Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences. J. Virol. 68, 2869-2878.
33. Tiemann, F., Zerrahn, J., and Deppert, W. (1995). Cooperation of simian virus 40 large and small T antigens in metabolic stabilization of tumor suppressor p53 during cellular transformation. J. Virol. 69, 6115-6121.
34. Viney, J.L. (1995). Transgenic and gene knockout mice in cancer research. Cancer Metastasis Rev. 14, 77-90.
35. Weinberg, R.A. (1995). The retinoblastoma protein and cell cycle. Cell 81, 323-330.
36. Weinberg, R.A. (1996). E2F and cell proliferation: a world turned upside down. Cell 85, 457-459.
37. Xiao, Z.X., Chen, J., Levine, A.J., Modjtahedi, N., Xing, J., Sellers, W.R., and Livingston, D.M. (1995). Interaction between the retinoblastoma protein and the oncoprotein mdm2. Nature 375, 694-698.